Background In August 2022, transgender activist Eli Erlick faced controversy after conservatives accused her of planning to distribute hormone therapy prescriptions to individuals in states where such treatments were being criminalized. The U.S. Drug Enforcement Administration (DEA) was called to investigate these allegations, though they have not commented on any ongoing investigation. Erlick has defended such actions as part of established mutual aid practices within the trans community to address healthcare access barriers.

Resolution Criteria This market will resolve YES if Eli Erlick is formally charged with a crime by any U.S. state or federal prosecutor related to hormone distribution or drug trafficking allegations before market close. The market will resolve NO if no charges are filed by market close.

For resolution purposes:

• Civil lawsuits do not count as prosecution

• Charges must be formally filed by a prosecutor's office

• Investigation announcements without formal charges do not count

• Charges must be related to hormone distribution or drug trafficking allegations from 2022 onwards

Considerations

• The current defamation lawsuit between Erlick and YouTuber Blaire White may impact public discourse around this topic but will not directly affect market resolution

• Law enforcement typically does not comment on ongoing investigations, so there may be limited public information available before any potential charges are filed